30 Day Trial

NuVasive Posts 1Q18 Revenue

Share:

NuVasive reported 1Q18 revenue of US $260.5MM, +4.6% vs. 1Q17.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.